Stock

Falling IPO Stocks Analysts Still Rate a Buy

109 IPO stocks have fallen over three months while the analyst consensus and our own score both stayed positive. The full screen, with the numbers.

This screen looks for one thing: a share price that has fallen over three months while both the analyst consensus and our own score stayed positive. It is a disagreement, not a verdict. Either the market has seen something the published views have not caught up with, or the views are right and the price overshot. The screen cannot tell you which — it tells you where to look, and shows the numbers that make each case.

Data as of 2026-11-09. 109 of 470 tracked IPOs qualify. Sorted by the three-month change, biggest fall first. The companion screen, where the price rose while the rating stayed cautious, runs the same test in the other direction.

Price fell, rating held

Flags
what we computewhat you can get elsewhere too
TickerCompanyOur balanceFundamentalsFlagsIPOMarket capLast3-monthSince IPOAnalyst indexConsensusTarget
as of 2026-11-17
WYFIWhiteFiber, Inc.Up +6
medium
loss-making -132.2%
revenue +66.2%
heavily indebted
Fell on sound metrics, Large daily move2025-08-07$427M$6.35-68.9%-42.2%0.2Strong Buy (11)$31.45 +395%
UMACUnusual Machines, Inc.Up +5
medium
loss-making -75.9%
revenue +101.2%
—2024-02-14$586M$8.64-62.6%+238.2%0.3Strong Buy (9)$30.11 +248%
BLZEBackblaze, Inc.Up +7
medium
loss-making -11.5%
revenue +14.3%
heavily indebted
Fell, analysts held, Improving confidence, Large daily move2021-11-11$489M$6.44-60.1%-56.7%1.5Buy (7)$21.50 +234%
BCAXBicara Therapeutics Inc.Up +8
medium
—Fell, analysts held2024-09-13$665M$8.44-59.8%-49.0%0.7Buy (14)$32.17 +281%
IRENIREN LimitedUp +7
strong
loss-making -194.4%
revenue +41.1%
heavily indebted
Fell on sound metrics, Improving confidence2021-11-17$7.7B$11.82-59.5%-34.0%1.1Buy (20)$56.69 +380%
CBRSCerebras Systems Inc.Up +4
medium
loss-making -86.2%
revenue +75.7%
heavily indebted
Lock-up expiry, Fell on sound metrics, Large daily move2026-05-14$26.4B$82.67-56.9%-36.9%0.9Strong Buy (11)$210.18 +154%
AESIAtlas Energy Solutions Inc.Leans up +3
medium
loss-making -13.0%
revenue +3.7%
heavily indebted
Fell, analysts held2023-03-09$698M$4.98-56.5%-52.9%1.0Buy (13)$15.38 +209%
AVBPArriVent BioPharma, Inc.Up +5
medium
—Fell, analysts held2024-01-26$673M$10.52-55.1%-29.3%0.0Strong Buy (11)$26.40 +151%
ITGITG, Inc.Up +4
medium
loss-making -1.3%
revenue +15.7%
heavily indebted
Fell on sound metrics, Large daily move2026-07-01$705M$5.53-54.2%-52.6%0.0Strong Buy (9)$11.33 +105%
CRDOCredo Technology Group Holding LtdUp +9
strong
profitable 33.8%
revenue +205.7%
—2022-01-27$24.7B$99.86-53.5%+2.1%0.0Strong Buy (20)$277.47 +178%
EROCERock, Inc.Up +5
medium
loss-making -2.9%
revenue +42.5%
heavily indebted
Fell on sound metrics2026-06-10$2.3B$6.12-51.7%-56.6%0.0Buy (8)$18.88 +208%
LGNLegence Corp.Up +9
strong
profitable 1.0%
revenue +21.5%
heavily indebted
—2025-09-12$3.8B$32.31-50.0%+63.1%0.0Strong Buy (17)$72.18 +123%
CRWVCoreWeave, Inc.Leans up +2
medium
loss-making -25.6%
revenue +167.9%
liquidity 0.4
heavily indebted
Thin liquidity2025-03-28$29.5B$39.51-49.9%+43.6%0.4Buy (41)$115.34 +192%
CADLCandel Therapeutics, Inc.Up +8
medium
heavily indebted
Fell, analysts held, Improving confidence, Large daily move2021-07-27$486M$5.04-49.0%-28.1%1.1Strong Buy (10)$17.67 +251%
INIOInnio N.V.Up +5
medium
profitable 2.7%
revenue +22.1%
heavily indebted
Lock-up expiry, Fell on sound metrics2026-06-04$10.9B$12.07-48.2%-35.7%0.5Buy (10)$31.40 +160%
APMDApnimed, Inc.Leans up +3
medium
revenue +380.1%
—2026-07-31$704M$16.09-48.0%+7.8%0.0Strong Buy (4)$50.33 +213%
QNTQuantinuum Inc.Up +4
medium
loss-making -106.4%
revenue +34.6%
heavily indebted
Lock-up expiry, Fell on sound metrics2026-06-04$9.4B$27.74-46.4%-51.4%0.5Strong Buy (14)$71.15 +156%
LIMENeutron Holdings, Inc.Up +7
strong
profitable 21.3%
revenue +29.1%
heavily indebted
—2026-07-01$1.3B$19.37-46.1%+3.4%0.0Strong Buy (8)$33.14 +71%
RAPPRapport Therapeutics, Inc.Up +5
medium
pre-revenue
heavily indebted
—2024-06-07$1.6B$23.16-46.0%+58.2%0.1Strong Buy (16)$64.21 +177%
ALHCAlignment Healthcare, Inc.Leans up +3
medium
profitable 0.6%
revenue +46.1%
heavily indebted
Weakening confidence2021-03-26$1.5B$6.37-45.3%—-2.9Buy (15)$10.79 +69%
NNENANO Nuclear Energy Inc.Up +4
medium
pre-revenue
—2024-05-08$597M$9.10-43.3%+174.0%-0.3Buy (9)$34.75 +282%
FPSForgent Power Solutions, Inc.Up +7
strong
profitable 7.4%
revenue +88.5%
heavily indebted
—2026-02-05$6.7B$18.00-43.0%+3.3%0.1Strong Buy (13)$42.85 +138%
AVRAnteris Technologies Global Corp.Leans up +2
split
pre-revenue
heavily indebted
Shrinking revenue, Large daily move2024-12-13$528M$4.99-42.5%-8.2%-0.8Strong Buy (5)$13.75 +176%
HMHHMH Holding Inc.Leans up +2
medium
loss-making -1.3%
revenue -2.6%
heavily indebted
Downgrade2026-04-01$542M$10.98-42.0%-2.1%-0.5Strong Buy (7)$22.43 +104%
CLYMClimb Bio, Inc.Leans up +3
medium
——2021-08-10$609M$9.19-40.6%-21.6%-0.2Strong Buy (16)$28.40 +209%
OMDAOmada Health, Inc.Up +7
strong
profitable 4.2%
revenue +53.2%
—2025-06-06$889M$11.87-39.7%-10.8%-0.1Buy (12)$26.50 +123%
GLUEMonte Rosa Therapeutics, Inc.Up +10
strong
loss-making -186.2%
revenue +63.5%
heavily indebted
Fell on sound metrics2021-06-24$801M$8.64-39.1%-50.4%0.3Strong Buy (10)$25.38 +194%
AVEXAEVEX Corp.Up +4
medium
profitable 3.6%
revenue +10.4%
heavily indebted
Lock-up expiry, Fell on sound metrics, Large daily move2026-04-17$1.6B$11.04-38.1%-29.3%-0.3Buy (10)$25.44 +130%
FRVOFervo Energy CompanyLeans up +3
split
pre-revenue
heavily indebted
Lock-up expiry, Fell, analysts held, Shrinking revenue, Improving confidence2026-05-13$3.4B$9.99-36.4%-61.0%8.1Strong Buy (16)$29.47 +195%
IEIvanhoe Electric Inc.Leans up +2
split
pre-revenue
heavily indebted
Fell, analysts held2022-06-28$1.1B$5.40-36.3%-42.7%0.0Buy (7)$20.58 +281%
DOCNDigitalOcean Holdings, Inc.Up +8
strong
profitable 3.1%
revenue +15.5%
heavily indebted
Improving confidence2021-03-24$10.2B$66.76-36.2%—1.6Strong Buy (17)$159.93 +140%
MPLTMapLight Therapeutics, Inc.Up +4
medium
——2025-10-27$403M$5.94-35.5%-58.3%-1.1Strong Buy (15)$26.54 +347%
KRMNKarman Holdings Inc.Up +7
strong
profitable 7.5%
revenue +36.6%
heavily indebted
Improving confidence2025-02-13$5.4B$29.25-34.2%+58.6%1.8Strong Buy (14)$67.00 +129%
DPCDPC Holdings PLCUp +7
strong
loss-making -16.8%
revenue +12.2%
heavily indebted
—2026-06-25$5.1B$30.74-33.4%+4.4%-0.3Buy (5)$52.20 +70%
ATTOAttovia Therapeutics, Inc.Up +5
medium
pre-revenue
—2026-08-05$691M$15.10-33.4%-12.3%0.5Strong Buy (5)$43.20 +186%
AKTSAktis Oncology, Inc.Up +7
strong
pre-revenue
revenue +336.9%
heavily indebted
—2026-01-09$927M$16.15-32.8%-14.8%0.3Strong Buy (10)$35.88 +122%
KARDKardigan, Inc.Up +6
medium
heavily indebted
—2026-06-18$1.3B$11.54-32.8%-20.9%0.7Strong Buy (9)$41.00 +255%
KGSKodiak Gas Services, Inc.Up +6
strong
profitable 11.3%
revenue +12.8%
heavily indebted
—2023-06-29$4.5B$39.67-32.4%+198.0%0.0Strong Buy (15)$72.64 +83%
CTNMContineum Therapeutics, Inc.Leans up +2
medium
heavily indebted
—2024-04-05$387M$8.68-32.1%-38.1%-1.0Buy (8)$21.43 +147%
WRDWeRide Inc.Up +4
medium
loss-making -199.0%
revenue +89.6%
heavily indebted
—2024-10-25$1.4B$2.99-31.9%-74.4%-0.8Strong Buy (13)$12.30 +312%
IMMXImmix Biopharma, Inc.Up +6
medium
——2021-12-16$657M$6.96-30.9%+41.2%0.4Strong Buy (7)$23.80 +242%
ALABAstera Labs, Inc.Up +6
strong
profitable 29.6%
revenue +115.1%
—2024-03-20$38.8B$180.35-30.7%+642.1%-0.3Buy (25)$344.15 +91%
DSGNDesign Therapeutics, Inc.Leans up +3
medium
——2021-03-26$670M$9.02-30.7%—0.4Strong Buy (8)$21.57 +139%
AIPArteris, Inc.Up +6
medium
loss-making -44.8%
revenue +22.3%
heavily indebted
Improving confidence2021-10-27$962M$16.50-30.5%+38.5%2.5Strong Buy (7)$33.00 +100%
AMBQAmbiq Micro, Inc.Up +4
medium
loss-making -29.7%
revenue -4.7%
Improving confidence2025-07-30$1.2B$39.68-30.1%+122.1%2.7Buy (7)$66.71 +68%
ARMArm Holdings plcLeans up +3
medium
profitable 17.1%
revenue +22.8%
heavily indebted
—2023-09-14$203.9B$152.20-29.8%+321.0%-0.3Buy (43)$272.43 +79%
FIGRFigure Technology Solutions, Inc.Up +9
strong
profitable 28.2%
revenue +55.7%
heavily indebted
Improving confidence2025-09-11$5.7B$23.84-29.5%-3.3%1.5Buy (10)$47.20 +98%
SINDSinda Ltd.Leans up +2
split
——2026-06-26$1.9B$9.09-29.1%-8.2%0.5Buy (6)$18.40 +102%
MNRMach Natural Resources LPLeans up +3
medium
profitable 20.7%
revenue +21.2%
liquidity 0.8
Fell on sound metrics, Profitable but deeply down, Thin liquidity2023-10-25$1.5B$7.95-28.8%-45.3%0.3Strong Buy (9)$16.29 +105%
BROSDutch Bros Inc.Up +5
medium
profitable 5.1%
revenue +27.9%
heavily indebted
—2021-09-15$6.4B$32.78-28.8%+102.8%-0.1Strong Buy (27)$55.04 +68%
PICSPicS N.V.Up +11
strong
profitable 14.6%
revenue +65.0%
heavily indebted
Fell on sound metrics, Profitable but deeply down2026-01-29$962M$5.02-27.4%-61.3%-0.4Strong Buy (9)$16.76 +234%
BKVBKV CorporationUp +5
strong
profitable 16.2%
revenue +41.6%
heavily indebted
—2024-09-26$2.1B$17.40-26.9%+22.4%0.0Strong Buy (11)$31.27 +80%
BTGOBitgo Holdings, Inc.Up +7
medium
loss-making -0.5%
heavily indebted
Fell, analysts held2026-01-22$496M$3.35-25.8%-75.8%0.0Strong Buy (12)$9.54 +185%
STUBStubHub Holdings, Inc.Leans up +2
split
loss-making -22.3%
revenue -1.4%
liquidity 1.0
heavily indebted
Fell, analysts held, Thin liquidity, Improving confidence2025-09-17$2.0B$4.54-25.4%-77.8%1.4Buy (14)$9.21 +103%
CSQRCsquare, Inc.Up +4
medium
loss-making -21.8%
revenue +8.8%
heavily indebted
Fell, analysts held2026-07-16$2.8B$14.52-25.2%-25.8%0.0Buy (10)$27.90 +92%
APCARKO Petroleum Corp.Leans up +3
split
profitable 0.7%
revenue -12.3%
heavily indebted
Shrinking revenue, Improving confidence2026-02-12$695M$13.13-25.0%-17.7%2.0Strong Buy (4)$21.25 +62%
TYRATyra Biosciences, Inc.Up +4
medium
——2021-09-15$1.4B$20.12-23.6%+26.2%-0.6Strong Buy (15)$47.45 +136%
PBLSParabilis Medicines, Inc.Up +4
medium
pre-revenue
heavily indebted
—2026-06-10$3.6B$27.44-23.6%+35.8%0.0Strong Buy (7)$41.00 +49%
BVSBioventus Inc.Leans up +2
medium
profitable 9.8%
revenue -0.9%
heavily indebted
—2021-02-11$898M$9.88-23.2%—0.0Strong Buy (5)$16.60 +68%
SKHYSK hynix Inc.Up +10
strong
profitable 70.1%
revenue +46.8%
heavily indebted
Improving confidence2026-07-10$663.0B$103.57-23.1%+2.6%1.0Strong Buy (15)$259.50 +151%
GENBGenerate Biomedicines, Inc.Up +5
medium
pre-revenue
revenue +55.9%
heavily indebted
—2026-02-27$1.6B$9.54-23.1%-23.7%0.0Strong Buy (5)$26.25 +175%
GFSGLOBALFOUNDRIES Inc.Up +4
medium
profitable 2.8%
revenue +0.6%
heavily indebted
Improving confidence2021-10-28$23.1B$35.56-22.4%-4.5%1.7Buy (23)$64.77 +82%
FIGFigma, Inc.Up +4
medium
loss-making -40.2%
revenue +41.0%
heavily indebted
Fell on sound metrics2025-07-31$10.4B$15.77-22.2%-30.4%0.7Buy (16)$27.41 +74%
HAWKHawkEye 360, Inc.Up +5
medium
loss-making -14.3%
revenue +162.6%
heavily indebted
Lock-up expiry, Fell on sound metrics, Improving confidence, Large daily move2026-05-07$1.8B$16.14-21.6%-35.5%1.1Strong Buy (11)$27.70 +72%
STDNStandard Nuclear, Inc.Leans up +2
medium
loss-making -210.5%
Fell, analysts held2026-07-16$1.7B$8.14-20.7%-31.5%-0.4Strong Buy (9)$16.88 +107%
ANLAdlai Nortye Group Ltd.Up +4
medium
heavily indebted
Fell, analysts held2023-09-29$683M$8.55-20.5%-58.0%0.0Strong Buy (7)$29.50 +245%
HSAIHesai GroupUp +4
medium
profitable 8.9%
revenue +45.8%
heavily indebted
—2023-02-09$2.3B$11.83-20.2%-34.9%-0.7Strong Buy (19)$23.37 +98%
ETOReToro Group Ltd.Leans up +3
medium
profitable 2.4%
revenue +9.4%
heavily indebted
Fell on sound metrics, Profitable but deeply down2025-05-14$1.8B$18.56-20.0%-57.5%0.0Buy (15)$36.60 +97%
MAIRMadison Air Solutions CorporationUp +6
medium
profitable 6.7%
revenue +34.1%
heavily indebted
Lock-up expiry, Improving confidence2026-04-16$14.1B$22.01-19.6%-11.1%1.6Strong Buy (10)$34.00 +54%
HOODRobinhood Markets, Inc.Up +5
medium
profitable 39.0%
revenue +51.6%
heavily indebted
Improving confidence2021-07-29$70.1B$62.17-19.1%+112.3%1.0Buy (32)$127.77 +106%
SSMRSunshine Silver Mining & Refining CompanyLeans up +3
medium
pre-revenue
Lock-up expiry2026-06-04$1.9B$10.45-18.8%-19.7%0.7Buy (6)$19.08 +83%
RIVNRivian Automotive, Inc.Up +7
medium
loss-making -45.9%
revenue +8.4%
heavily indebted
Fell, analysts held, Upgrade, Improving confidence2021-11-10$17.8B$10.33-18.1%-84.9%1.1Buy (25)$17.94 +74%
MBXMBX Biosciences, Inc.Up +7
medium
—Improving confidence2024-09-13$2.8B$49.55-18.0%+270.4%1.3Strong Buy (12)$95.09 +92%
CAVACAVA Group, Inc.Leans up +3
medium
profitable 4.5%
revenue +22.4%
heavily indebted
Improving confidence2023-06-15$6.8B$48.84-18.0%+177.7%1.5Buy (27)$75.42 +54%
COMPCompass, Inc.Leans up +3
medium
profitable 1.1%
revenue +23.7%
heavily indebted
—2021-04-01$7.8B$9.64-17.6%—-0.4Buy (12)$12.46 +29%
EROKEagleRock Land, LLCUp +4
strong
profitable 37.4%
revenue +699.0%
heavily indebted
Lock-up expiry2026-05-14$2.8B$19.70-17.5%+9.4%0.0Buy (6)$27.33 +39%
BZKanzhun LimitedUp +5
medium
profitable 52.9%
revenue +12.4%
—2021-06-11$5.8B$12.87-16.7%—-0.2Strong Buy (22)$20.74 +61%
GMRSGMR Solutions Inc.Up +4
medium
profitable 3.8%
revenue -4.0%
heavily indebted
Lock-up expiry, Fell on sound metrics2026-05-13$1.0B$10.12-16.6%-31.3%0.0Buy (8)$18.38 +82%
CRCLCircle Internet Group, Inc.Up +5
strong
profitable 15.3%
revenue +63.9%
—2025-06-05$16.0B$47.51-16.6%+113.1%0.8Buy (29)$102.37 +115%
RLXRLX Technology Inc.Up +6
strong
profitable 21.9%
revenue +48.0%
—2021-01-22$1.9B$1.40-16.6%—0.3Strong Buy (6)$2.78 +99%
QQnity Electronics, Inc.Up +6
strong
profitable 10.2%
revenue +9.7%
heavily indebted
—2025-10-27$24.7B$103.47-15.9%—0.4Strong Buy (10)$173.30 +67%
VORVor Biopharma Inc.Leans up +2
split
——2021-02-05$1.2B$19.19-15.6%—0.2Strong Buy (10)$39.00 +103%
IPSCCentury Therapeutics, Inc.Leans up +2
split
heavily indebted
—2021-06-17$300M$1.17-15.4%—0.0Buy (5)$4.75 +308%
COINCoinbase Global, Inc.Leans up +2
medium
loss-making -12.5%
revenue +9.4%
heavily indebted
—2021-04-15$33.8B$101.97-15.2%—0.3Buy (37)$195.00 +91%
AUNAAuna S.A.Up +5
strong
profitable 0.3%
revenue -0.0%
heavily indebted
Fell on sound metrics, Profitable but deeply down2024-03-22$340M$3.66-14.7%-63.2%0.0Buy (7)$6.99 +91%
IMCRImmunocore Holdings plcLeans up +2
weak
loss-making -7.5%
revenue +28.9%
heavily indebted
—2021-02-05$1.5B$26.41-14.6%—-1.2Buy (12)$59.40 +125%
BLSMBlossomHill Therapeutics, Inc.Leans up +3
medium
heavily indebted
—2026-08-07$446M$14.51-14.4%-19.4%0.0Strong Buy (5)$35.40 +144%
ERASErasca, Inc.Leans up +2
medium
heavily indebted
—2021-07-16$5.5B$13.61-14.3%-4.6%0.2Buy (9)$24.11 +77%
RELYRemitly Global, Inc.Up +9
strong
profitable 19.1%
revenue +29.4%
heavily indebted
Fell on sound metrics, Profitable but deeply down2021-09-23$4.8B$19.83-14.3%-40.5%0.0Strong Buy (10)$32.00 +61%
WBIWaterBridge Infrastructure LLCUp +7
strong
profitable 1.2%
revenue +66.2%
heavily indebted
Improving confidence2025-09-17$3.4B$24.91-13.6%+55.5%1.7Buy (8)$36.75 +48%
TCBXThird Coast Bancshares, Inc.Up +4
medium
profitable 30.7%
revenue +21.9%
heavily indebted
Improving confidence2021-11-09$661M$37.05-13.3%+66.4%1.8Buy (7)$47.36 +28%
CINTCI&T Inc.Up +7
strong
profitable 6.3%
revenue +11.6%
heavily indebted
Profitable but deeply down2021-11-10$390M$2.68-13.3%-79.5%-1.0Buy (10)$5.63 +110%
DCDakota Gold Corp.Leans up +2
split
——2022-04-05$715M$4.11-13.1%—0.2Strong Buy (6)$12.26 +198%
AFRMAffirm Holdings, Inc.Up +6
strong
profitable 43.9%
revenue +32.1%
heavily indebted
—2021-01-13$22.1B$54.00-12.6%—0.5Buy (36)$95.81 +77%
MWHSOLV Energy, Inc.Up +4
medium
profitable 4.1%
revenue +34.8%
heavily indebted
—2026-02-11$5.6B$24.69-11.8%+4.1%-0.9Strong Buy (11)$40.55 +64%
JCAPJefferson Capital, Inc.Up +5
strong
profitable 23.6%
revenue +41.5%
heavily indebted
Large daily move2025-06-26$1.2B$20.72-11.7%+42.4%0.0Buy (5)$28.60 +38%
VERAVera Therapeutics, Inc.Leans up +3
medium
pre-revenue
heavily indebted
—2021-05-14$2.0B$25.45-11.2%—-0.7Strong Buy (14)$71.36 +180%
NUNu Holdings Ltd.Up +6
strong
profitable 27.1%
revenue +28.5%
heavily indebted
Large daily move2021-12-09$64.0B$11.27-10.3%+41.9%-1.1Buy (23)$17.83 +58%
VIKViking Holdings LtdUp +5
split
profitable 18.6%
revenue +21.9%
liquidity 0.8
heavily indebted
Thin liquidity, Upgrade, Improving confidence2024-05-01$40.1B$94.02-10.0%+272.6%2.3Strong Buy (23)$110.05 +17%
AVAHAveanna Healthcare Holdings Inc.Leans up +3
medium
profitable 11.4%
revenue +20.2%
heavily indebted
Improving confidence2021-04-29$2.5B$11.01-9.4%—1.4Buy (11)$15.20 +38%
KSPIJoint Stock Company Kaspi.kzLeans up +3
medium
profitable 24.3%
revenue +59.8%
heavily indebted
—2024-01-19$17.1B$83.51-9.2%-0.5%0.0Buy (7)$106.52 +28%
NHPNational Healthcare Properties, Inc.Leans up +3
strong
loss-making -3.4%
revenue -3.2%
heavily indebted
Lock-up expiry, Thin liquidity2026-04-22$1.1B$14.82-9.2%+24.1%0.6Buy (8)$19.57 +32%
MHMcGraw Hill, Inc.Up +5
medium
profitable 3.5%
revenue +0.1%
liquidity 0.9
heavily indebted
Thin liquidity2025-07-24$2.2B$12.05-9.2%-19.7%0.0Strong Buy (13)$17.33 +44%
FLOCFlowco Holdings Inc.Up +5
strong
profitable 6.4%
revenue +41.9%
heavily indebted
—2025-01-16$1.9B$18.94-9.1%-15.1%-0.9Buy (9)$29.78 +57%
ABSIAbsci CorporationLeans up +3
split
pre-revenue
Fell, analysts held, Shrinking revenue, Large daily move2021-07-22$1.5B$7.51-8.6%-49.7%0.6Strong Buy (12)$15.09 +101%
TUYATuya Inc.Leans up +3
medium
profitable 20.2%
revenue +7.8%
—2021-03-18$999M$1.46-8.4%—-0.3Strong Buy (4)$3.17 +117%
ZBIOZenas BioPharma, Inc.Up +4
medium
pre-revenue
revenue +100.0%
—2024-09-13$1.9B$23.85-8.2%+61.0%0.0Strong Buy (8)$47.88 +101%
ASAmer Sports, Inc.Up +5
medium
profitable 8.2%
revenue +26.7%
heavily indebted
—2024-02-01$17.4B$28.27-8.1%+124.5%-0.2Strong Buy (27)$47.47 +68%
LBLandBridge CorporationLeans up +3
medium
profitable 17.1%
revenue +81.1%
heavily indebted
—2024-06-28$5.6B$70.39-8.0%+424.8%0.0Buy (7)$89.57 +27%
ARXSArxis, Inc.Up +6
strong
profitable 6.5%
revenue +115.5%
heavily indebted
Lock-up expiry2026-04-16$23.0B$48.46-7.5%+93.4%0.5Strong Buy (11)$66.50 +37%
AURAAura Biosciences, Inc.Leans up +3
medium
heavily indebted
Fell, analysts held2021-10-29$740M$6.87-7.4%-53.3%0.0Strong Buy (6)$16.60 +142%
FLYFirefly Aerospace Inc.Leans up +3
medium
loss-making -88.4%
revenue +162.9%
heavily indebted
Fell on sound metrics2025-08-07$4.3B$17.69-7.2%-56.0%0.3Buy (11)$36.64 +107%
LBRXLB Pharmaceuticals IncUp +4
medium
——2025-09-11$1.4B$38.85-7.0%+166.5%-1.0Strong Buy (11)$58.00 +49%
SUNSSunrise Realty Trust, Inc.Leans up +2
medium
profitable 34.9%
revenue +143.2%
heavily indebted
—2024-07-09$98M$6.41-7.0%—0.0Buy (4)$10.13 +58%
SMWBSimilarweb Ltd.Up +4
medium
loss-making -4.6%
revenue +13.1%
liquidity 0.8
heavily indebted
Thin liquidity, Improving confidence2021-05-12$703M$7.74-6.9%—1.1Buy (8)$10.83 +40%
TPGTPG Inc.Leans up +2
medium
profitable 7.5%
revenue +27.0%
heavily indebted
—2022-01-13$18.6B$44.32-6.8%+69.5%0.6Buy (17)$59.53 +34%
VINPVinci Compass Investments Ltd.Up +5
strong
profitable 30.1%
revenue +62.7%
heavily indebted
—2021-01-28$577M$8.01-6.7%—0.0Buy (6)$12.63 +58%
INRInfinity Natural Resources, Inc.Leans up +3
medium
profitable 7.9%
revenue +37.6%
liquidity 0.7
heavily indebted
Thin liquidity2025-01-31$821M$10.92-6.6%-29.3%-0.6Strong Buy (9)$21.11 +93%
TTANServiceTitan, Inc.Up +4
medium
loss-making -12.1%
revenue +24.5%
heavily indebted
—2024-12-12$8.0B$76.23-6.5%+18.0%0.0Buy (18)$96.81 +27%
BBNXBeta Bionics, Inc.Leans up +3
medium
loss-making -65.3%
revenue +53.9%
—2025-01-30$893M$13.36-6.5%-2.2%-0.2Buy (15)$25.10 +88%
PHVSPharvaris N.V.Leans up +3
medium
——2021-02-05$2.3B$31.28-5.5%—0.9Strong Buy (14)$58.16 +86%
DSPViant Technology Inc.Leans up +3
medium
profitable 1.9%
revenue +19.0%
heavily indebted
—2021-02-10$781M$10.07-5.5%—0.0Strong Buy (11)$19.32 +92%
FSBCFive Star BancorpUp +5
medium
profitable 41.3%
revenue +25.7%
heavily indebted
—2021-05-05$1.1B$40.99-5.4%—0.0Buy (5)$51.40 +25%
LIFEEthos Technologies Inc.Up +4
medium
loss-making -16.2%
revenue +52.0%
—2026-01-29$2.2B$31.22-5.4%+122.7%-0.6Strong Buy (9)$53.38 +71%
SPCXSpace Exploration Technologies Corp.Up +8
strong
loss-making -8.6%
revenue +33.2%
heavily indebted
Improving confidence2026-06-12$1.89T$127.79-4.9%+4.7%1.5Buy (40)$255.63 +100%
ALHAlliance Laundry Holdings Inc.Leans up +2
medium
profitable 11.7%
heavily indebted
—2025-10-09$4.6B$24.27-4.7%+7.0%0.0Strong Buy (8)$31.00 +28%
VGVenture Global, Inc.Leans up +3
medium
profitable 31.1%
revenue +176.9%
liquidity 0.9
heavily indebted
Profitable but deeply down, Thin liquidity, Improving confidence2025-01-24$33.1B$11.95-4.4%-41.3%1.6Buy (17)$17.56 +47%
PAYPPayPay CorporationUp +9
strong
profitable 16.3%
revenue +25.9%
heavily indebted
—2026-03-12$9.7B$11.67-4.1%-13.1%0.8Strong Buy (13)$23.67 +103%
ALMRAlamar Biosciences, Inc.Up +4
strong
loss-making -48.2%
revenue +195.2%
heavily indebted
Lock-up expiry2026-04-17$2.1B$26.48-4.1%+87.0%0.0Buy (5)$37.00 +40%
NXTNextpower Inc.Up +6
medium
profitable 16.0%
revenue +20.3%
Improving confidence2023-02-09$14.3B$67.13-4.1%+244.0%1.4Strong Buy (30)$127.90 +91%
FVRFrontView REIT, Inc.Leans up +3
medium
loss-making -0.0%
revenue +341.0%
heavily indebted
Thin liquidity2024-10-02$583M$17.97-4.1%-2.7%0.7Buy (11)$21.64 +20%
LOARLoar Holdings Inc.Up +4
strong
profitable 9.4%
revenue +23.2%
heavily indebted
—2024-04-25$7.0B$63.64-3.9%+140.8%-1.0Buy (5)$88.80 +40%
COCOThe Vita Coco Company, Inc.Up +4
medium
profitable 15.7%
revenue +18.2%
heavily indebted
—2021-10-21$3.6B$64.37-3.6%+292.2%0.3Buy (12)$79.10 +23%
SEPNSepterna, Inc.Leans up +2
medium
loss-making -61.3%
revenue +4174.5%
heavily indebted
—2024-10-25$2.0B$38.61-3.6%+109.3%0.1Strong Buy (10)$59.22 +53%
CGONCG Oncology, Inc.Up +5
strong
pre-revenue
—2024-01-25$6.6B$79.47-3.5%+219.3%-0.8Strong Buy (14)$92.15 +16%
SGMTSagimet Biosciences Inc.Up +4
medium
——2023-07-14$729M$9.08-2.0%-37.2%-1.0Buy (12)$27.27 +200%
FRBTForbright, Inc.Up +6
strong
profitable 20.4%
revenue +29.5%
heavily indebted
—2026-06-11$951M$16.70-1.9%+2.5%0.8Buy (6)$23.25 +39%
YMMFull Truck Alliance Co. Ltd.Up +8
strong
profitable 35.9%
revenue +11.1%
Fell on sound metrics, Profitable but deeply down2021-06-22$9.0B$8.82-1.7%-56.5%0.6Buy (15)$12.51 +42%
VNOMViper Energy, Inc.Up +5
medium
profitable 12.1%
revenue +62.1%
heavily indebted
—2025-08-19$15.3B$39.69-1.6%—-0.6Strong Buy (20)$55.45 +40%
DLODLocal LimitedUp +7
strong
profitable 14.9%
revenue +46.6%
heavily indebted
Improving confidence2021-06-03$3.9B$12.04-1.6%—1.0Buy (10)$18.50 +54%
PTRNPattern Group Inc.Up +7
strong
profitable 3.6%
revenue +39.3%
heavily indebted
Upgrade2025-09-19$3.6B$18.51-1.4%+32.4%-0.1Strong Buy (9)$27.88 +51%
TRINTrinity Capital Inc.Leans up +2
weak
profitable 67.4%
revenue +16.6%
heavily indebted
—2021-01-29$1.7B$16.63-1.2%—0.0Buy (9)$19.00 +14%
TWFGTWFG, Inc.Leans up +2
medium
profitable 2.8%
revenue +20.8%
heavily indebted
—2024-07-18$1.4B$25.66-1.1%+54.4%0.6Buy (8)$31.71 +24%
YSWYYesway, Inc.Up +5
strong
profitable 1.1%
revenue +5.8%
heavily indebted
Lock-up expiry2026-04-22$1.6B$20.11-0.8%+27.4%0.6Buy (9)$29.63 +47%
WHKWhiteHawk Minerals Corp.Up +5
strong
loss-making -78.4%
revenue +427.7%
heavily indebted
—2026-06-09$791M$23.88-0.5%+2.2%0.0Strong Buy (5)$32.40 +36%

Showing 145 of 477 tracked IPOs. Our balance, the flags, the fundamentals and the analyst figures come from the weekly run of 2026-11-17. Prices are refreshed daily and were last taken on 2026-11-20; a thinly traded company shows its most recent trade, which may be older. Use the filters to narrow the list, or click a column heading to sort.

The three-month window is deliberate. A week is noise and a year buries the move in the IPO itself; three months is long enough for a repricing and short enough that the published views have had time to react and have not. Where a company carries a Lock-up expiry flag, part of the fall may be supply rather than sentiment — the dates are on the Key Dates page, with how many normal trading sessions the unlocking stock would take to absorb.

How to read this. Our score runs from −10 to +10 and is computed here from the filings and the price history, not copied from anyone — the Scores page sets out what goes into it and Method says where every figure comes from. Our view is the direction that score leans, in words. Consensus is the analyst consensus with the number of analysts behind it in brackets; a consensus resting on four or five people is not the same object as one resting on thirty, which is why the count is always shown. Implied upside is the consensus target against the latest close. The 3-month change is highlighted where the move is 40% or more in either direction. Of the 470 listed IPOs we track, 105 are left out of both screens before anything is ranked: 9 are under a takeover offer, 32 carry no consensus target at all, 36 are followed by fewer than four analysts, 7 trade below a dollar, and 21 show an implied upside above 300%, counting each by the first test it fails. Two of those deserve a word. A target three times the share price is almost always a target nobody has revised, not a bullish call. And a company under a takeover offer is not a disagreement at all: the price tracks the bid and the rating goes to hold, which is the mechanism working, not a gap between the market and the page. A disagreement is not a forecast and not a recommendation: it says the price and the published view have moved apart, and gives you the pieces to work out which one you find more convincing. Nothing on this page is a recommendation to buy or sell.